6th Annual World Life Sciences Conference
1 Jun - 2 Jun 2018
Session information
Roundtables - Topic five Parallel trade: genuine vs artificial parallel trade
Friday 1 June (0930 - 1230)
Committee(s)
Intellectual Property and Entertainment Law Committee
(Lead)
Life Sciences Subcommittee
(Lead)
Description
Genuine parallel trade is the natural consequence of price differentials in the relevant markets, provided that they arise from the market operators’ freedom to set prices. Artificial parallel trade is a form of arbitrage that derives from the price differences provoked by governmental coercive price controlling. What are the legitimate pricing and supply schemes that could be put in place by pharma companies in order to avoid undesirable flows of products from low-price countries into high-price countries?
Session / Workshop Chair(s)
| Eduardo Hallak | Licks Attorneys, São Paulo, Brazil |
| Stephanie Pautke | COMMEO Rechtsanwälte PartGmbB , Frankfurt, Germany; Committee Liaison Officer, Healthcare and Life Sciences Law Committee |
| Teresa Paz-Ares | Uria Menendez, Madrid, Spain; Vice Chair, Data Law Subcommittee |